HER-2 Negative Breast Cancer Market Is Estimated to Witness High Growth Owing to Increasing prevalence
HER-2 negative breast cancer is an aggressive type of breast cancer that lacks human epidermal growth factor receptor 2 (HER2) protein over-expression or HER2 gene amplification. The conventional treatment of HER-2 negative breast cancer involves a combination of surgery, chemotherapy and radiation therapy depending on the stage and characteristics of cancer. New targeted therapies are being...
0 Reacties 0 aandelen 606 Views 0 voorbeeld
Sponsor